TNF-α mediates PKR-dependent memory impairment and brain IRS-1 inhibition induced by Alzheimer's β-amyloid oligomers in mice and monkeys.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cell Metabolism

• Publication date

  2013-12-03

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.cmet.2013.11.002PMID 24315369
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Suppression of eIF2α kinases alleviates AD-related synaptic plasticity and spatial memory deficits

  2013cited by this paper
• Alzheimer's disease and insulin resistance: translating basic science into clinical applications.

  2013cited by this paper
• Memantine Rescues Transient Cognitive Impairment Caused by High-Molecular-Weight Aβ Oligomers But Not the Persistent Impairment Induced by Low-Molecular-Weight Oligomers

  2013cited by this paper
• Longevity effect of IGF-1R+/− mutation depends on genetic background-specific receptor activation

  2013cited by this paper
• Different β-amyloid oligomer assemblies in Alzheimer brains correlate with age of disease onset and impaired cholinergic activity.

  2012cited by this paper
• Amyloid-β oligomers link depressive-like behavior and cognitive deficits in mice

  2012cited by this paper
• Sustained translational repression by eIF2α-P mediates prion neurodegeneration

  2012influential reference
• Amyloid-β Oligomers Induce Differential Gene Expression in Adult Human Brain Slices*

  2012cited by this paper
• Tumor Necrosis Factor-Induced Cerebral Insulin Resistance in Alzheimer's Disease Links Numerous Treatment Rationales

  2012cited by this paper
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

  2012cited by this paper
• JNK3 perpetuates metabolic stress induced by Aβ peptides.

  2012influential reference
• Insulin Receptor β-Subunit Haploinsufficiency Impairs Hippocampal Late-Phase LTP and Recognition Memory

  2012cited by this paper
• Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

  2012cited by this paper
• An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

  2012cited by this paper
• Liraglutide: once‐daily GLP‐1 agonist for the treatment of type 2 diabetes

  2011cited by this paper
• Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition.

  2011cited by this paper
• The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

  2011cited by this paper
• The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease

  2011influential reference
• Influence of the Hepatic Eukaryotic Initiation Factor 2α (eIF2α) Endoplasmic Reticulum (ER) Stress Response Pathway on Insulin-mediated ER Stress and Hepatic and Peripheral Glucose Metabolism

  2011cited by this paper
• Amyloid β-Peptide Oligomers Stimulate RyR-Mediated Ca2+ Release Inducing Mitochondrial Fragmentation in Hippocampal Neurons and Prevent RyR-Mediated Dendritic Spine Remodeling Produced by BDNF

  2011cited by this paper
• Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes.

  2011cited by this paper
• Inflammatory mechanisms in obesity.

  2011influential reference
• Defects in IGF-1 receptor, insulin receptor and IRS-1/2 in Alzheimer's disease indicate possible resistance to IGF-1 and insulin signalling.

  2010cited by this paper
• Translational Control Mechanisms in Long-lasting Synaptic Plasticity and Memory*

  2010cited by this paper
• GLP-1 Receptor Stimulation Reduces Amyloid-β Peptide Accumulation and Cytotoxicity in Cellular and Animal Models of Alzheimer's Disease

  2010cited by this paper
• The regulatory subunits of PI3K, p85α and p85β, interact with XBP-1 and increase its nuclear translocation

  2010cited by this paper
• Endoplasmic reticulum stress and the inflammatory basis of metabolic disease.

  2010influential reference
• A Mouse Model of Amyloid β Oligomers: Their Contribution to Synaptic Alteration, Abnormal Tau Phosphorylation, Glial Activation, and Neuronal Loss In Vivo

  2010cited by this paper
• Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis.

  2010influential reference
• ER Calcium and Alzheimer’s Disease: In a State of Flux

  2010cited by this paper
• A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box–binding protein-1 to modulate the unfolded protein response

  2010cited by this paper
• The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus.

  2009cited by this paper
• Protection of synapses against Alzheimer's-linked toxins: Insulin signaling prevents the pathogenic binding of Aβ oligomers

  2009cited by this paper
• β-Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin

  2009cited by this paper
• PERK and PKR: Old kinases learn new tricks

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers.

  2008cited by this paper
• Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis.

  2008cited by this paper
• Double stranded RNA activated EIF2 alpha kinase (EIF2AK2; PKR) is associated with Alzheimer's disease.

  2008cited by this paper
• Amyloid beta oligomers induce impairment of neuronal insulin receptors

  2008cited by this paper
• Double stranded RNA activated EIF2 α kinase (EIF2AK2; PKR) is associated with Alzheimer's disease

  2008cited by this paper
• Alzheimer's Disease is Type 3 Diabetes—Evidence Reviewed

  2008cited by this paper
• Alzheimer's disease-type neuronal tau hyperphosphorylation induced by Aβ oligomers

  2008cited by this paper
• Insulin receptor signaling regulates synapse number, dendritic plasticity, and circuit function in vivo.

  2008cited by this paper
• Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice.

  2007cited by this paper
• Endoplasmic reticulum stress: signaling the unfolded protein response.

  2007cited by this paper
• Aβ Oligomers Induce Neuronal Oxidative Stress through an N-Methyl-D-aspartate Receptor-dependent Mechanism That Is Blocked by the Alzheimer Drug Memantine*

  2007cited by this paper
• Aβ Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

  2007cited by this paper
• Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice

  2007cited by this paper
• Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.

  2007cited by this paper
• Effects of intranasal insulin on cognition in memory-impaired older adults: modulation by APOE genotype.

  2006cited by this paper
• GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress.

  2006cited by this paper
• Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling.

  2006cited by this paper
• Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes

  2006cited by this paper
• GLP-1 receptor activation improves β cell function and survival following induction of endoplasmic reticulum stress

  2006cited by this paper
• The unfolded protein response is activated in Alzheimer’s disease

  2005cited by this paper
• Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner

  2005cited by this paper
• Role for neuronal insulin resistance in neurodegenerative diseases.

  2004cited by this paper
• Intranasal insulin improves memory in humans.

  2004cited by this paper
• Increased risk of type 2 diabetes in Alzheimer disease.

  2004cited by this paper
• Role for neuronal insulin resistance in neurodegenerative diseases

  2004cited by this paper
• Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

  2004cited by this paper
• Alzheimer's disease-affected brain: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss

  2003cited by this paper
• Co-expression of multiple transgenes in mouse CNS: a comparison of strategies.

  2001cited by this paper
• IRS-1-Mediated Inhibition of Insulin Receptor Tyrosine Kinase Activity in TNF-α- and Obesity-Induced Insulin Resistance

  1996cited by this paper
• Deficient signaling in mice devoid of double‐stranded RNA‐dependent protein kinase.

  1995cited by this paper
• Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-alpha.

  1994cited by this paper
• Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection.

  1993cited by this paper
• Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

  1991cited by this paper
• Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study

  year unknowncited by this paper

• Therapeutic Options for Alzheimer’s Disease and Aging-Associated Cognitive Decline: State of the Art in the ACH2.0 Paradigm

  2026cites this paper
• The Muscle–Brain Axis in Aging: Mechanistic and Clinical Perspectives on Resistance Training and Cognitive Function

  2026cites this paper
• Pharmacological inhibition of protein kinase R by C16: A multifaceted modulator of stress-induced cell death

  2026cites this paper
• Soluble and plaque amyloid associations with peripheral glucose dysregulation modulated by tau pathology in Alzheimer’s disease

  2026cites this paper
• Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists.

  2026cites this paper
• The momentum for dementia research in Brazil

  2026cites this paper
• Innate Immune Tolerance Regulates Microglia Response to Aβ Oligomers

  2026cites this paper
• Tau-induced ribosomal collisions impair memory through the activation of the integrated stress response

  2026cites this paper
• The integrated stress response in the brain: cell type-specific functions in health and neurological disorders.

  2025cites this paper
• PKR-driven ISR signaling controls synaptic translation and structural plasticity in an age-dependent manner.

  2025cites this paper
• Repeated blood-brain barrier opening using low-intensity pulsed ultrasound mitigates amyloid pathology

  2025cites this paper
• Neuroimaging and molecular mechanism of action of Cang-ai volatile oil in the treatment of vascular cognitive impairment

  2025cites this paper
• Neuroinflammation Based Neurodegenerative In Vitro Model of SH-SY5Y Cells—Differential Effects on Oxidative Stress and Insulin Resistance Relevant to Alzheimer’s Pathology

  2025cites this paper
• Antidiabetic GLP-1 Receptor Agonists Have Neuroprotective Properties in Experimental Animal Models of Alzheimer’s Disease

  2025cites this paper
• Physical activity in Alzheimer's disease prevention: Sex differences and the roles of BDNF and irisin.

  2025cites this paper
• Peptide OM-LV20 demonstrates neuroprotective effects by attenuating mitochondria-mediated neuronal apoptosis and dysfunction in mice with traumatic brain injury.

  2025cites this paper
• Production of Amyloid-β in the Aβ-Protein-Precursor Proteolytic Pathway Is Discontinued or Severely Suppressed in Alzheimer’s Disease-Affected Neurons: Contesting the ‘Obvious’

  2025cites this paper
• Alzheimer’s Is a Multiform Disease of Sustained Neuronal Integrated Stress Response Driven by the C99 Fragment Generated Independently of AβPP; Proteolytic Production of Aβ Is Suppressed in AD-Affected Neurons: Evolution of a Theory

  2025cites this paper
• RNA dysregulation in neurodegenerative diseases

  2025cites this paper
• Neural Metabolic Networks: Key Elements of Healthy Brain Function

  2025cites this paper
• Aβ42 induces stress granule formation via PACT/PKR pathway

  2025cites this paper
• TNF as a mediator of metabolic inflammation and body-brain interaction in obesity-driven neuroinflammation and neurodegeneration.

  2025cites this paper
• Integrator loss leads to dsRNA formation that triggers the integrated stress response.

  2025cites this paper
• Incretin Hormones GLP-1 and GIP Normalize Energy Utilization and Reduce Inflammation in the Brain in Alzheimer’s Disease and Parkinson’s Disease: From Repurposed GLP-1 Receptor Agonists to Novel Dual GLP-1/GIP Receptor Agonists as Potential Disease-Modifying Therapies

  2025cites this paper
• Neuron type-specific mRNA translation programs provide a gateway for memory consolidation

  2025cites this paper
• Innovations in Alzheimer’s disease diagnostic technologies: clinical prospects of novel biomarkers, multimodal integration, and non-invasive detection

  2025cites this paper
• Multi-target approach to Alzheimer’s disease prevention and treatment: antioxidant, anti-inflammatory, and amyloid- modulating mechanisms

  2025cites this paper
• Energy metabolism in health and diseases

  2025cites this paper
• Comparative analysis of hippocampal volume and stress levels between medical and non-medical undergraduate female students

  2025cites this paper
• Stepwise Ligand Capture Primes PKR for Activation and RNA Discrimination

  2025cites this paper
• Diabetic retinopathy and Alzheimer's disease: Convergence of the unfolded protein response in neurodegeneration

  2025cites this paper
• The novel sphingolipids cP1P and P1P attenuate neuroinflammation and enhance S1PR1/Akt/mTOR signaling to mitigate cognitive decline in an Alzheimer’s disease mouse model

  2025cites this paper
• Incretin-based therapeutics for the treatment of neurodegenerative diseases

  2025cites this paper
• Neonatal maternal separation causes depressive-like behavior and potentiates memory impairment induced by amyloid-β oligomers in adult mice

  2025cites this paper
• Linking Circadian Rhythms to Gut‐Brain Axis Lipid Metabolism Associated With Endoplasmic Reticulum Stress in Alzheimer's Disease

  2025cites this paper
• Insulin resistance in Alzheimer's disease: signalling mechanisms and therapeutics strategies

  2025cites this paper
• Chronic IL-21 drives neuroinflammation and promotes lipid accumulation in microglia

  2025cites this paper
• The Phytochemical Agathisflavone Modulates miR146a and miR155 in Activated Microglia Involving STAT3 Signaling

  2024cites this paper
• Exploring the therapeutic potential of quercetin: A focus on its sirtuin‐mediated benefits

  2024cites this paper
• Identification of RN7SK LncRNA as a novel biomarker in Alzheimer’s disease using bioinformatics and expression analysis

  2024cites this paper
• On the Inadequacy of the Current Transgenic Animal Models of Alzheimer’s Disease: The Path Forward

  2024cites this paper
• The Role of the Integrated Stress Response (ISR) in Neuropsychiatric Disorders

  2024cites this paper
• Role of the integrated stress response system (ISR) in neuropsychiatric pathologies of the central nervous system

  2024cites this paper
• ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer’s Disease: Origins, Progression, and Therapeutic Strategies

  2024cites this paper
• A neurodegenerative cellular stress response linked to dark microglia and toxic lipid secretion.

  2024cites this paper
• Peroxiredoxin 1 inhibits streptozotocin-induced Alzheimer’s disease-like pathology in hippocampal neuronal cells via the blocking of Ca2+/Calpain/Cdk5-mediated mitochondrial fragmentation

  2024cites this paper
• Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target.

  2024cites this paper
• Genetic Reduction of the Translational Repressors FMRP and 4E‐BP2 Preserves Memory in Mouse Models of Alzheimer's Disease

  2024cites this paper
• Patient-derived tau and amyloid-β facilitate long-term depression in vivo: role of tumour necrosis factor-α and the integrated stress response

  2024cites this paper
• Defective regulation of the eIF2-eIF2B translational axis underlies depressive-like behavior in mice and correlates with major depressive disorder in humans

  2024cites this paper
• Can infliximab serve as a new therapy for neuropsychiatric symptoms?

  2024cites this paper
• Quintessential Synergy: Concurrent Transient Administration of Integrated Stress Response Inhibitors and BACE1 and/or BACE2 Activators as the Optimal Therapeutic Strategy for Alzheimer’s Disease

  2024cites this paper
• Involvement of inflammasomes in the pathogenesis of Alzheimer's disease

  2024cites this paper
• Sleep-wake behavior and responses to sleep deprivation and immune challenge of protein kinase RNA-activated knockout mice

  2024cites this paper
• Targeting soluble amyloid-beta oligomers with a novel nanobody

  2024cites this paper
• The Novel Lipid Emulsion Vegaven Is Well Tolerated and Elicits Distinct Biological Actions Compared With a Mixed-Oil Lipid Emulsion Containing Fish Oil: A Parenteral Nutrition Trial in Piglets

  2024cites this paper
• Somatostatin: Linking Cognition and Alzheimer Disease to Therapeutic Targeting

  2024cites this paper
• Unveiling the functional components and anti-Alzheimer's activity of Koelreuteria elegans (Seem.) A.C. Sm. using UHPLC-MS/MS and molecular networking

  2024cites this paper
• Single-cell RNA-sequencing analysis reveals α-syn induced astrocyte-neuron crosstalk-mediated neurotoxicity.

  2024cites this paper
• The integrated stress response in brain diseases: A double-edged sword for proteostasis and synapses.

  2024cites this paper
• Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome

  2024cites this paper
• Oral administration of liposome-encapsulated thymol could alleviate the inflammatory parameters in serum and hippocampus in a rat model of Alzheimer's disease.

  2024cites this paper
• Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.

  2024cites this paper
• The ketamine metabolite (2R,6R)‐hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer's disease

  2024cites this paper
• GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review.

  2024cites this paper
• GW9508 ameliorates cognitive dysfunction via autophagy pathway in streptozotocin‐induced mouse model of Alzheimer's disease

  2024cites this paper
• TARGETING SOLUBLE AMYLOID-BETA OLIGOMERS WITH A NOVEL NANOBODY

  2024cites this paper
• T-regulatory cells and extracellular vesicles in Alzheimer's disease: New therapeutic concepts and hypotheses.

  2024cites this paper
• CHCHD10S59L/+ mouse model: Behavioral and neuropathological features of frontotemporal dementia.

  2024cites this paper
• Fu's subcutaneous needling promotes axonal regeneration and remyelination by inhibiting inflammation and endoplasmic reticulum stress.

  2024cites this paper
• The role of peripheral β-amyloid in insulin resistance, insulin secretion, and prediabetes: in vitro and population-based studies

  2023cites this paper
• Emerging concepts towards a translational framework in Alzheimer's disease.

  2023cites this paper
• Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer’s Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (iAβ) by Its Targeted Degradation via Augmentation of Intra-iAβ-Cleaving Activities of BACE1 and/or BACE2

  2023cites this paper
• Evaluating the Role of N-Acetyl-L-Tryptophan in the Aβ 1-42-Induced Neuroinflammation and Cognitive Decline in Alzheimer’s Disease

  2023cites this paper
• Voluntary running wheel exercise induces cognitive improvement post traumatic brain injury in mouse model through redressing aberrant excitation regulated by voltage-gated sodium channels 1.1, 1.3, and 1.6

  2023cites this paper
• Principles of Design of Clinical Trials for Prevention and Treatment of Alzheimer’s Disease and Aging-Associated Cognitive Decline in the ACH2.0 Perspective: Potential Outcomes, Challenges, and Solutions

  2023cites this paper
• Research Mechanism and Progress of the Natural Compound Curcumin in Treating Alzheimer´s Disease.

  2023cites this paper
• Synaptic proteasome is inhibited in Alzheimer’s disease models and associates with memory impairment in mice

  2023influential citation
• Association of the fibronectin type III domain–containing protein 5 rs1746661 single nucleotide polymorphism with reduced brain glucose metabolism in elderly humans

  2023cites this paper
• The Amyloid Cascade Hypothesis 2.0 for Alzheimer’s Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy

  2023cites this paper
• Has-miR-129-5p’s Involvement in Different Disorders, from Digestive Cancer to Neurodegenerative Diseases

  2023cites this paper
• The ketamine metabolite (2R,6R)-hydroxynorketamine rescues hippocampal mRNA translation, synaptic plasticity and memory in mouse models of Alzheimer’s disease

  2023cites this paper
• Preface: Special issue “ Brain Proteostasis in Health and Disease ”

  2023cites this paper
• The integrated stress response effector GADD34 is repurposed by neurons to promote stimulus-induced translation

  2023cites this paper
• Receptor–ligand interaction controls microglial chemotaxis and amelioration of Alzheimer's disease pathology

  2023cites this paper
• Impact of NLRP3 Depletion on Aging-Related Metaflammation, Cognitive Function, and Social Behavior in Mice

  2023cites this paper
• The role of ADAM17 in cerebrovascular and cognitive function in the APP/PS1 mouse model of Alzheimer’s disease

  2023cites this paper
• Messenger RNA Translation Defects in Neurodegenerative Diseases.

  2023cites this paper
• Defective proteostasis in Alzheimer's disease.

  2023cites this paper
• AVE 0991 Suppresses Astrocyte-Mediated Neuroinflammation of Alzheimer’s Disease by Enhancing Autophagy

  2023cites this paper
• Revisiting the intersection of microglial activation and neuroinflammation in Alzheimer's disease from the perspective of ferroptosis.

  2023cites this paper
• Oxytocin attenuates microglial activation and restores social and non-social memory in APP/PS1 Alzheimer model mice

  2023cites this paper
• Apoptotic cell death in disease—Current understanding of the NCCD 2023

  2023cites this paper
• The subcortical default mode network and Alzheimer’s disease: a systematic review and meta-analysis

  2023cites this paper
• Pharmacological and physiological roles of adipokines and myokines in metabolic-related dementia.

  2023cites this paper
• Impaired insulin signalling and allostatic load in Alzheimer disease

  2022cites this paper
• Inflammation at the crossroads of COVID-19, cognitive deficits and depression

  2022cites this paper
• Insulin Resistance in the Brain: Evidence Supporting a Role for Inflammation, Reactive Microglia, and the Impact of Biological Sex

  2022cites this paper
• Lesions without symptoms: understanding resilience to Alzheimer disease neuropathological changes

  2022cites this paper
• Intrathecal amyloid‐beta oligomer administration increases tau phosphorylation in the medial temporal lobe in the African green monkey: A nonhuman primate model of Alzheimer's disease

  2022cites this paper